Clinical Trial Update: Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC) [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial update noting that recruitment is ongoing for hepatic intra-arterial therapy in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Hepatic IA Therapy

Snippet

Sponsor: Koo Foundation Sun Yat-Sen Cancer Center | Conditions: Hepatocellular Carcinoma (HCC) | EARLY_Phase 1 | Status: RECRUITING